Improvements to vaccinia virus expression vectors continue to be made. In particular, there are new methods for the construction of recombinant viruses, ways of increasing the level of gene expression, and vectors that allow the inducible expression of selected genes.
Epstein-Barr virus vectors for gene expression and transfer
✍ Scribed by Christopher R Sclimenti; Michele P Calos
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 338 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0958-1669
No coin nor oath required. For personal study only.
✦ Synopsis
Vectors based on components of Epstein-Barr virus (EBV) have found increasingly wide applications in biotechnology. Three areas of recent advancement comprise the use of EBV vectors to improve the convenience of gene expression systems, the development of EBV vectors for gene transfer in gene therapy, and the use of EBV components to generate large vectors carrying sizable regions of genomic DNA.
📜 SIMILAR VOLUMES
Three stages of maturation can be seen in keratinizing nasopharyngeal carcinomas. These stages are similar morphologically to basal cells, intermediate and superficial squamous cells seen in normal squamous epithelium. Taking advantage of such a diverse tumour cell population, 10 keratinizing nasoph
## Abstract Epstein‐Barr virus (EBV) latent and replicative gene transcription was analyzed in peripheral blood B‐lymphocytes from astronauts who flew on short‐duration (∼11 days) Shuttle missions and long‐duration (∼180 days) International Space Station (ISS) missions. Latent, immediate‐early, and
## Abstract Immunosuppressed pediatric transplant recipients are at risk of developing Epstein–Barr virus (EBV)‐associated complications (such as post‐transplant lymphoproliferative disorders). Monitoring of the EBV DNA level in blood alone has a low predictive value for the post‐transplant course